List view / Grid view

Roche

 

news

FDA grants Priority Review for venetoclax NDA

12 January 2016 | By Victoria White

The NDA for venetoclax is for the treatment of people with chronic lymphocytic leukaemia who have received at least one prior therapy, including those with 17p deletion...

news

EC approves Cotellic plus Zelboraf in advanced melanoma

25 November 2015 | By Victoria White

The approval is based on data that showed Cotellic plus Zelboraf helped people with previously untreated BRAF V600 mutation-positive advanced melanoma live for more than a year without their disease worsening...